Ранняя диагностика папилломавирусной инфекции гениталий у женщин репродуктивного возраста методом полимеразной цепной реакции
Диссертация
За последнее десятилетие накоплен большой фактический материал по вопросу гистофизиологии и патологии шейки матки (Кондриков Н.И., 1997, Кулаков В. И., 2000). Важное место в классификации заболеваний женских половых органов занимает раздел «Эпителиальные опухоли и связанные с ними поражения». Особой сложностью ранней диагностики характеризуются процессы, связанные с папилломавирусной инфекцией… Читать ещё >
Список литературы
- Agarossi A., Casolati Е., Valieri М. et al. Mucosal immune response to Human Papilloma Virus (HPV) infection in HIV positive women.//Med Wieku Rozwoj, 2003 V.7(4 Pt 1), P.495−502
- Anhang R., Goodman A., Goldie S.J. HPV Communication: Review of existing research and recommendations for patient education//CA Cancer J Clin, 2004, V54, P.248−259
- Arends M.J., Buckley C.H., Wells M. Aetiology, pathogenesis and pathology of cervical neoplasia// J. Clinical Patology, 1998, V.51, P.96−103
- Bachtiary В., Obermair A., et al. Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer//International J. of Cancer, 2002, V.102, P.23 7−243
- Belinson J., Qiao Y.L., Pretorius R., et al. Shanxi province cervical cancer screening study: a cross sectional comparative trial of multiple techniques to detect cervical neoplasia//Gynecological Oncology, 2001, V.83, P.439−444
- Benton EC, Arends MJ, Human papillomaviruses in the immunosu-pressed//Lacey C., ed. Papillomavirus reviews: current research on papillomaviruses, Leeds university Press, 1996, P.271−279
- Bosch X., Lorincz A., Munoz N., et al. The casual relation between human papillomavirus and cervical cancer//J. Clinical Pathology, 2002, V.55, P.244−265
- Bosch X., de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer burden and assessment of causality//J. Natl Cancer Inst Monogr, 2003, V.31, P.3−13
- Buxton E.J., Luesley D.M., Shafi M.I. et al. Colposcopically directed punch biopsy: a potentially misleading investigation//Br J Obstetric Gynaecol, 1991 V.98(12), P.1273−1276
- Castellague X., Bosch X., Munoz N. The male role in cervical cancer//Salud Publica Мех, 2003, V.45 suppl 3, P.345−353
- Castellague X., Munoz N Chapter 3: Cofactors in human papillomavirus can-cerogenesis -role of parity, oral contraceptives, and tobacco smoking//J. Natl Cancer Inst Mnogr, 2003, V.31, P.20−28
- Chan S.Y., Delius H., Halpern A.L., et al. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny and taxonomy//J.Virology, 1995, V.69 P.3074−3083
- Clavel C., Masure M., Boiy J.P., et al. human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women//British J. of Cancer, 2001, V.84, P. 1616−1623
- Cronje H.S., Screening for cervical cancer in developing coun-tries//International J. of Gynecology and Obstetrics, 2004, V. 84(2), PI 01−108
- Cuzick J., Sasieni P. Estimates of the cost impact of introducing human papillomavirus testing into a cervical screening programme// New developments in cervical cancer screening and prevention, 1997, P.364−372
- Cuzick J., Szarewski A., Cubie H., et al. HPV testing may replace Pap smears for primary screening//The J. of family practice, 2004, V.53
- Dalstein V., Riethmuller D., et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study//International J. of cancer, 2003, V.106, P.396−403
- Delius H., Hofmann B. Primer-directed sequencing of human papillomavirus types// Curr. Top Microbiology Immunology, 1994, V.186, P. 13−32
- Denny LA, Soeters R, Dehaeck К et al. Does colposcopically directed punch biopsy reduce the incidence of negative LLETZ?//Br J Obstet Gynaecol., 1995, V. 102(7), P.545−548
- Ferenczy A. The Bethesda System (TBA): Advantages and pitfalls// New developments in cervical cancer screening and prevention, 1997, P. 151−158
- Ferenczy A, Coutlee F, Franco E, et al. Human papillomavirus and HIV coin-fection and the risk of neoplasias of the lower genital tract: a review of recent developments.//CMAJ, 2003 V. 169(5), P.431−434
- Fife K.H., Cramer H.M., et al. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia/Я. Medical Virology, 2001, V.64, P. 550−559
- Franco E.L. Primary screening of cervical cancer with human papillomavirus tests//J. Natl Cancer Inst Monogr, 2003, V.31, P.89−96
- Gravitt P.E., Peyton C.L. et al. Genotyping of 27 human papillomavirus types by using LI consensus PCR products by a single-hybridization, reverse line blot detection method//J. of Clinical Microbiology, 1998, V.36, P3020−3027
- GravittP.E., Peyton C.L. et al. Improved amplification of Genital Human Papillomaviruses//!. of Clinical Microbiology, 2000, V.38, P.357−361
- Greer C.E., Wheeler C.M., Lander M.B., et al. Human papillomavirus (HPV) type distribution and serological response to HPV6 virus-like particles in patients with genital warts// J. Clinical microbiology, 1995, V.33, P.2058−2063
- Harkness C.B., Theofrastous J.P., Ibrahim S.N. et al. Papanicolaou and thin-layer cervical cytology with colposcopic biopsy control. A comparison. //J. Re-prod Med., 2003, V.48(9), P.681−686
- Heid C.A. Real-time quantitative PCR//Genome Res., 1996., V.6, P.986−994.
- Higuchi R. Kinetic PCR Analysis: Real-time monitoring of DNA amplification reactions//! Biotechnology, 1993, V. ll, P 1026−1030
- Holmes J, HemmettL, Garfield S. The cost-effectiveness of human papillomavirus screening for cervical cancer A review of recent modelling studies//Eur J Health Econ., 2005
- Howley P.M., Lowy D.R. Papillomaviruses and their replication// Fields Virology 4th ed., editors-in-chief Knipe D.M., Howley P.M., Philadelphia, Lippin-cott Williams & Wilkins, 2001, V.2, P.2197−2229th
- Howley P.M., Lowy D.R. Papillomaviruses// Fields Virology 4 ed., editors-in-chief Knipe D.M., Howley P.M., Philadelphia, Lippincott Williams & Wilkins, 2001, V.2, P.2230−2264
- Hudelist G., Manavi M., et al. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are con-elated with lesion grade//J. Gynecology Oncology, 2004, V.92, P.873−880
- J.M.M. Walboomers The Prevalence of HPV in a Normal Screening Population// www.digene.com/chamonix/abstracts/walboomers.htm, 1999
- Jacobs M.V. Roda Husman A.M. et al. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails о oligonucleotide probes//J. of Clinical Microbiology, 1995, V.33,P.901−905
- Josefsson A.M., Magnusson P.K., Ylitalo N. et al. Viral load of human papillomavirus 16 as a determinant for development of cervical carcinoma in situ: a nested-case control study//Lancet, 2000, V.355,P.2189−2193
- Kim J.J., Wright T.C., Goldie S.J. Cost-effectiveness of alternative triage strategies for atypical scuamouse cell of undetermined significance//JAMA, 2002, V.287, P.2382−2390
- Klimov E., Vinokourova S., Mojsjalc E. Human papillomaviruses and cervical tumors: mapping of integration sites and analylis of adjacent cellular se-quences//BMC Cancer, 2002, V.2(l) P.24
- Koutsky L.A., Holmes K.K., Critchlow C.W., et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus in-fection//New England J. of medicine, 1992, V.327, P.1272−1278
- Kreuger Fre A.F., Beerman H., Nijs Huub G.T., van Ballegooijen M. Positive diagnostic values and histological detection ratios from the Rotterdam cervical cancer screening programme// International J. of epidemiology, 1998, V.27, P.377−381
- Lee S.A., Kang D., et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip//Cancer Lett., 2003, V.20, P. 187−192
- Lorincz A.T. Methods of DNA Hybridization and their clinical applicability to human pappilomavirus detection// New developments in cervical cancer screening and prevention, 1997, P.325−337
- Lorincz A.T. Screening for cervical cancer: new alternatives and re-search//Salud Publica Мех., 2003, V.45
- Meijer С .J.L.M., Rozendaal L., Van der Linden J.C., et al. Human papillomavirus testing for primary cervical cancer screening//New developments in cervical cancer screening and prevention, 1997, P.338−347
- Meyer Т., Arndt R. Characterization of HPV 73 as a cancer-associated high-risk HPV type//Eurogin 2000, 2000, P.397−401
- Moore Т.О., Moore A.Y., Carrasco D et al. Human papillomavirus, smoking, and cancer.//J. Cutan Med Surg, 2001, V5(4), P.323−328
- Munoz N., Bosch X. et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective/VIntemational J. of Cancer, 2004, V. l 11(2), P.278−285
- Munoz N., Bosch X. et al. Epidemiologic classification of Human Papillomavirus types associated with cervical cancer// New England J. of medicine, 2003, V.348, P518−527
- Munoz N. Human papillomavirus and cervical cancer: epidemiological evi-dence//New developments in cervical cancer screening and prevention, 1997, P.3−13
- Munoz N. Human papillomavirus vaccines and their potential use in the prevention and treatment of cervical neoplasia// New developments in cervical cancer screening and prevention, 1997, P.425−431
- Nanda K., McCrory D.C., Myers E.R., et al. Accuracy of Papanicolaou test in screening for and follow-up of cervical cytology abnormalities: a systematic re-view//Ann Intern Med, 2000, V. l32, P.810−819
- National center of HIV, STD and ТВ Prevention Tracing the hidden epidemics 2000//www.cdc.gov/nchstp/od/news/RevBrochurelpdfcloselookhpv.htm. 2000
- Negri G., Menia E., Egailer-Vigl E. et al. ThinPrep versus conventional Papanicolaou smear in the cytologic follow-up of women with equivocal cervical smears//Cancer, 2003, V.99(6), P.342−345
- Palefsky J.M., Holly E.A. Immunosupression and coinfection with HIV//J. Natl Cancer Inst Monogr, 2003, V.31, P.41−46
- Petry U., Menton S., Menton M. et al. Inclusion of HPV-testing for routine cervical cancer screening for women above 29 years in Gemany: results for 8466 patients//British J. of Cancer, 2003, V.88, P.1570−1577
- Poljak M., Marin I.J., et al. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail//!. Clinical Virology, 2002, V.25, P.89−97
- Romanczuk H., Howley P.M. Disruption of either El or E2 regulatory gene of human papillomavirus type 16 increases virus immortalization capacity// Proc National Academy of Science USA, 1992, V.89, P.3159−3163
- Rouseau M.C., Abrahamowicz M. et al. Predictors of cervical coinfection with multiple human papillomavirus types//Cancer Epidemiology Biomarkers Pre v., 2003, V.12, P.1029−1037
- Sang B.C., Barbosa M.S. Single aminoacid substitution in «low-risk» human papillomavirus (HPV) type 6 E7 protein enhance features characteristics of «high-risk» HPV E7 oncoproteins//Proc National Academy of Science USA, 1992, V.89, P.8063−8067
- Saslow D., Runowicz C.D., Solomon D. American cancer society guideline for the early detection of cervical neoplasia and cancer//CA Cancer J. Clin, 2002, V.52, P.342−362
- Schiffman M., Kjaer S.K. Natural history of anogenital human papillomavirus infection and neoplasia//.!. Natl Cancer Inst Monogr, 2003, V.31, P. 14−19
- Tarn L.S., Chan A.Y., Chan P.K. et al. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection.// Arthritis Rheum., 2004, V.50(l l), P.3619−3625
- Taylor G., Wolff Т., Khanna N. et al. Genital dysplasia in women infected with human immunodeficiency virus.//J Am Board Fam Pract., 2004, V.17(2), P.108−13
- Watanabe S., ICanda Т., Yoshiike K. Human papillomavirus type 16 transformation of primary embryonic fibroblasts requires expression of open reading frames E6 and E7//J.Virology, 1989, V.63, P.965−969
- Weimin Q.U., Jiang G. et al. PCR Detection of Human Papillomavirus: Comparison between MY09/MY11 and GP5+/GP6+ primer system//J. of Clinical Virology, 1997, V.35, P.1304−1310
- Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus types 16 and 18 proteins with p53//Science, 1990, V.248, P.76−79
- Wright T.C., Schiffrnan M., Solomon D. et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening//Obstetrics and Gynecology, 2004, V.103, P.304−308
- Аксель E.M., Давыдов М. И. Статистика заболеваемости и смертности от злокачественных новообразований в 2000 году//Злокачественные новообразования в России и странах СНГ в 2000, г. Москва, 2002, с.85−106
- Андреев А.И. Возможности цитологического и гистологического методов в диагностике плоских кондилом шейки матки//Акушерство и гинекология, 1990,-№ 2.- с.35−40
- Гуменюк Е.Г. Роль вируса папилломы человека в возникновении гинекологической и онкологической патологии//доклад на Республиканском семинаре врачей акушеров-гинекологов 18−19.04.2001, http://home.onego.ru/~rpcopb/works/
- Двойрин В.В., Аксель М. Е., Трапезников Н. Н. Статистика злокачественных новообразований в России и некоторых странах СНГ в 1990—1994 гг..г.-М., 1995
- Екимов А.Н., Шипулин Г. А. и соавт. Новейшие технологии в генодиагностике: полимеразная цепная реакция в реальном времени (Real-Time PCRy/Вестник последипломного медицинского образования, 2001, № 3
- Подистов Ю.И., Лактионов К. П., Петровичев Н. Н. Современные диагностические возможности в определении предрака и рака шейки матки//Ж. Клиническая лабораторная диагностика, 2003, № 3
- Прилепская В.Н., Кондриков Н. И., Бебнева Т. Н. Значение вируса папилломы человека в развитии диспластических процессов шейки мат-KH//www.consilium-medicum.com/media/gynecology/OQ 03/80.shtml, 2000
- Прилепская В.Н., Роговская С. И., Межевитинова Е. А. Кольпоско-пия.//Практическое руководство. М. 1997
- Радзинский В.Е., Буянова С. Н., Манухин И. Б., Кондриков Н.И.- под ред. Краснопольского В. И. Патология влагалища и шейки матки //. М., Медицина, 1997
- Роговская С.И., Бебнева Т. Н. Папилломавирусная инфекция гениталий. Клиника и лечение//Заболевания шейки матки, влагалища и вульвы, под ред. проф. Прилепской В. Н., М., МЕДпресс, 2000, С.240−253
- Русакевич П.С. Заболевания шейки матки: симптоматика, диагностика, лечение, профилактика//Минск, «Вышэйшая школа», 2002, стр. 198−306
- Сирйонен К. Репродуктивное здоровье, редкие инфекции: пер. с англ.'//Под ред. Л. Кейта, Г. Бергера, Д. Эдельмана.-М., 1998 т.2, с. 169−189.
- Шаймарданова Г. И., Савичева A.M., Максимов С. Я. Клинические проявления папилломавирусной инфекции гениталий у женщин// Журнал акушерства и женских болезней.- 2001.- Выпуск 2.- Том XLX.